Data / Form D filings / Human Longevity, Inc.
Human Longevity, Inc.: Form D filings
Human Longevity, Inc., a biotechnology company in San Diego, CA, filed 4 Form D notices with the SEC between 2019 and 2024. The latest, on August 21, 2024, reports $32 million sold of a $32 million offering to 18 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4570 EXECUTIVE DRIVE, San Diego, CA, 92121
- Phone
- (844) 838-3322
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1781303
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 21, 2024 | Amendment | $31,999,999 | $31,999,999 | 18 | Mar 13, 2023 | sec.gov | |
| Apr 7, 2023 | New notice | $22,500,000 | $10,500,000 | $12,000,000 | 4 | Mar 13, 2023 | sec.gov |
| Oct 11, 2022 | New notice | $11,703,581 | $6,919,380 | $4,784,201 | 11 | Sep 27, 2021 | sec.gov |
| Jul 1, 2019 | New notice | $30,032,965 | $20,060,630 | $9,972,335 | 1 | Jun 14, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Wei-Wu He | Director | |
| James Huang | Director | |
| Helmut Schuehsler | Director | |
| David Karow | Executive Officer, Director | |
| James Hu | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 19, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Human Longevity, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.